The healthcare sector is trading higher today, driven by strong quarterly earnings and an increased full-year forecast from medical device giant Medtronic. Adding to the positive sentiment, pharmaceutical company GSK announced it will advance its mRNA seasonal flu vaccine to Phase III trials following successful Phase II results, signaling a potential new product in a major market. These positive developments from key industry leaders are boosting investor confidence across the healthcare sector.